The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q2 2016 call → NOWe need answer YES/NO. Need analyze transcript. Question asks: Does management convey company has recently finished expensive/uncertain/heavy phase of major undertaking and now entered collecting phase, with reported results still mostly reflecting paying phase rather than collecting phase? Need identify if management describes such lifecycle. Candidate: Big Fish UA spending? They increased UA spend, recognized immediately, revenue over lifetime. But are they "finished heavy phase"? No, they continue investing. Or TwinSpires move? No. Casino hotel build? Not finished, going out to bid, site work before Q3, open middle next year. No. Maybe Big Fish: They launched Jackpot City Slots, investing UA. Not finished heavy phase. They say "we continue to invest meaningful UA dollars" and will decrease slightly in H2. That's ongoing. Not "heavy phase done". Also "we are just focused on us; lots of work to do to significantly grow Big Fish over long-term." So no. Maybe "Kentucky Derby Week" completed and now collecting? No, event happened; results reflect. Maybe "we built the right facility in the right location" for Miami Valley, and it's gaining share. That's a completed major undertaking? They built facility earlier? But this call mentions Miami Valley again gained market share, grew revenue/EBITDA. But is that "recently finished expensive phase" and "reported results still mostly reflect paying phase"? No, they are already benefiting, results reflect. Maybe "we decided to move headquarters" - not finished. Question specifically: management conveys completed heavy phase and now collecting but reported results still lag. Look for phrases like "de-risked", "built", "completed", "behind us". In transcript: "we built the right facility in the right location" - past. But no indication results still lag. Big Fish UA spending: They say UA expense recognized immediately, revenue over lifetime. So when they spend more UA, current EBITDA reduced, future revenue comes. They increased UA in Q2 vs prior year, decreased vs Q1. They anticipate UA spend will decrease slightly in H2. Does that mean heavy phase is done? They invested in scaling games; now they are optimizing, decreasing spend. But revenue from UA will come over time.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.